Galmed Pharmaceuticals Ltd. buy Stifel Nicolaus
Start price
08.05.24
/
50%
€0.38
Target price
08.05.25
€65.08
Performance (%)
1602.13%
End price
09.05.25
-
Summary
This prediction is currently being closed. With a performance of 1602.13% the BUY prediction by Stifel_Nicolaus is a big success. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - | - |
| iShares Core DAX® | 0.231% | -2.413% | 15.337% |
| iShares Nasdaq 100 | 1.663% | -1.658% | 31.087% |
| iShares Nikkei 225® | -0.208% | -2.502% | 43.625% |
| iShares S&P 500 | 1.067% | -1.579% | 24.346% |
Comments by Stifel_Nicolaus for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Stifel Nicolaus from $64.00 to $70.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Stifel_Nicolaus for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
21.02.25
21.02.25
€89.66
21.02.26
21.02.26
-
22.02.26
22.02.26
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
06.11.24
06.11.24
€85.67
06.11.25
06.11.25
-
07.11.25
07.11.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.34
21.02.24
21.02.24
€59.19
21.02.25
21.02.25
1782.35%
22.02.25
22.02.25